Trademark: 88658162
Status Date
Tuesday, December 19, 2023
Filing Date
Thursday, October 17, 2019
Published for Opposition
Tuesday, April 6, 2021
36 pharmaceutical benefit management services; reimbursement payment processing in the field of pharmaceutical claims; providing financial information relating to drug pricing and actuarial services to others; pharmacy network management in the nature of monitoring financial performance of pharmacies
35 Pharmacy business services in the nature of pharmaceutical cost management services and drug utilization review services, management services provided to pharmacies for controlling drug inventories, business administration of drug reimbursement programs and services, managed care services, namely, drug utilization review and pre-certification services; drug utilization review in the nature of health care utilization and review services, pharmaceutical cost management services and drug utilization review services, duplication of drug therapy; providing pharmaceutical data and analytics to others in the nature of analyzing pharmacy claims data to present cost and utilization trend information, projecting drug spending, modeling rebate scenarios and opportunities, conducting repricing analyses, evaluating the performance of clinical pharmacy programs; business administration services, namely, pharmacy network management in the nature of coordination of medication fulfillment to appropriate pharmacy types, coordination of retail, mail, online, and specialty pharmacies to establish pharmacy networks which can be accessed by providers, patients, and members, coordination and support of the delivery of pharmacy services of ambulatory infusion centers, durable medical equipment, prosthetics, orthotics, and medical supplies containing an assigned National Drug Code product identifier; pharmacy business investigations in the nature of contract compliance and fraud, waste, and abuse investigations; professional pharmacy credentialing verification services in the field of health, namely, verifying the skills and knowledge of pharmacists on behalf of others, and conducting audits
44 medication therapy management services in the nature of medication compliance and medication counseling
42 drug utilization review in the nature of providing educational information for proper medication utilization to medical, pharmaceutical, and dental providers and members; medical research in the nature of drug utilization review for drug interactions, duplication of drug therapy, contraindications; medical research, namely, drug utilization review in the nature of drug interactions and contraindications
IONIC HEALTH; ION IQ HEALTH
"HEALTH"
Dec 20, 2023
Notice Of Approval Of Extension Request E-Mailed
Dec 19, 2023
Sou Extension 5 Granted
Nov 30, 2023
Sou Extension 5 Filed
Dec 19, 2023
Case Assigned To Intent To Use Paralegal
Nov 30, 2023
Sou Teas Extension Received
Nov 6, 2023
Assigned To Examiner
Jun 1, 2023
Notice Of Approval Of Extension Request E-Mailed
May 30, 2023
Sou Extension 4 Granted
May 30, 2023
Sou Extension 4 Filed
May 30, 2023
Sou Teas Extension Received
Feb 17, 2023
Teas Change Of Correspondence Received
Feb 17, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Feb 17, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Nov 12, 2022
Notice Of Approval Of Extension Request E-Mailed
Nov 10, 2022
Sou Extension 3 Granted
Nov 10, 2022
Sou Extension 3 Filed
Nov 10, 2022
Sou Teas Extension Received
Apr 15, 2022
Notice Of Approval Of Extension Request E-Mailed
Apr 13, 2022
Sou Extension 2 Granted
Apr 13, 2022
Sou Extension 2 Filed
Apr 13, 2022
Sou Teas Extension Received
Nov 2, 2021
Notice Of Approval Of Extension Request E-Mailed
Oct 29, 2021
Sou Extension 1 Granted
Oct 29, 2021
Sou Extension 1 Filed
Oct 29, 2021
Sou Teas Extension Received
Jun 1, 2021
Noa E-Mailed - Sou Required From Applicant
Apr 6, 2021
Official Gazette Publication Confirmation E-Mailed
Apr 6, 2021
Published For Opposition
Mar 17, 2021
Notification Of Notice Of Publication E-Mailed
Feb 26, 2021
Approved For Pub - Principal Register
Feb 25, 2021
Examiner's Amendment Entered
Feb 25, 2021
Notification Of Examiners Amendment E-Mailed
Feb 25, 2021
Examiners Amendment E-Mailed
Feb 25, 2021
Examiners Amendment -Written
Feb 18, 2021
Teas/Email Correspondence Entered
Feb 17, 2021
Correspondence Received In Law Office
Feb 17, 2021
Teas Request For Reconsideration Received
Aug 18, 2020
Notification Of Final Refusal Emailed
Aug 18, 2020
Final Refusal E-Mailed
Aug 18, 2020
Final Refusal Written
Jul 28, 2020
Teas/Email Correspondence Entered
Jul 27, 2020
Correspondence Received In Law Office
Jul 27, 2020
Teas Response To Office Action Received
Jan 26, 2020
Notification Of Non-Final Action E-Mailed
Jan 26, 2020
Non-Final Action E-Mailed
Jan 26, 2020
Non-Final Action Written
Jan 23, 2020
Assigned To Examiner
Oct 21, 2019
New Application Office Supplied Data Entered
Oct 21, 2019
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
